Search Results - Sicen Pan
- Showing 1 - 1 results of 1
-
1
Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system by Rui Xiong, Jing Lei, Sicen Pan, Hong Zhang, Yongtao Tong, Wei Wu, Yi Huang, Xiaodan Lai
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book